Bicara Therapeutics Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $96.6M | $323.5M | $96.7M | $171.7M | $436.6M | $462.1M | $489.7M | $520.8M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $503.8M | $544.9M | $422.1M | $297.4M | $444.4M | $470.8M | $502.5M | $521.5M |
| Property, Plant & Equipment | $362.0K | $346.0K | $330.0K | $135.0K | $117.0K | $136.0K | $155.0K | $130.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $512.2M | $553.6M | $431.0M | $424.7M | $453.6M | $478.1M | $510.0M | $524.2M |
| Liabilities | ||||||||
| Accounts Payable | — | — | — | — | — | — | — | — |
| Total Current Liabilities | $43.5M | $39.3M | $28.9M | $21.0M | $17.2M | $19.1M | $18.0M | $14.5M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $43.5M | $39.6M | $29.5M | $21.9M | $18.4M | $19.1M | $18.1M | $14.6M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-470.6M | $-415.2M | $-359.0M | $-321.6M | $-285.3M | $-257.9M | $-221.0M | $-200.1M |
| Total Stockholders' Equity | $468.8M | $514.0M | $401.5M | $402.8M | $435.2M | $459.0M | $491.9M | $509.6M |